Jeffrey S. Bornstein - Director at Kalaris Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
KLRS on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Jeffrey S. Bornstein since 01 Feb 2025

Holdings reported by Jeffrey S. Bornstein for Kalaris Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 110,197 $87,309 $0.7923 06 Jun 2024 Direct

Transactions reported by Jeffrey S. Bornstein for Kalaris Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.